☆ 4.6 Article

Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects

MICROBIOLOGY SPECTRUM (2021)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

Meng Yuan et al.

Summary: Since the outbreak of COVID-19 pandemic, researchers from diverse biomedical and biological disciplines have collaborated to study the novel pandemic virus SARS-CoV-2. The focus has been on the antibody response to SARS-CoV-2, crucial for vaccine and therapeutic development. Most of the neutralizing antibodies for SARS-CoV-2 target the spike protein receptor binding domain (RBD).

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Medical Laboratory Technology

Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test

Antonin Bal et al.

Summary: The study found that the Wantai Total Ab assay targeting the receptor binding domain (RBD) within the S protein showed the best sensitivity at different stages of the disease. With the exception of the Euroimmun IgA assay, all other tests had clinical specificity greater than 95%. Some commercial serological assays demonstrated better agreement with the VNT compared to others, but they cannot replace the VNT for assessing functional antibody response.

CLINICAL CHEMISTRY (2021)

Add to Collection

Letter Medicine, General & Internal

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Alicia T. Widge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Review Virology

Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design

Xuhua Xia

Summary: This article delves into the structure and function of the spike protein in SARS-CoV-2, aiming to enhance the mechanistic understanding of how it mediates cell entry and transmission, as well as discussing important issues related to vaccine development and the emergence of viral variants.

VIRUSES-BASEL (2021)

Add to Collection

Article Immunology

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Agnes Bonifacius et al.

Summary: Research showed that active COVID-19 patients had high levels of anti-SARS-CoV-2 nucleocapsid and spike IgG, but overall reduced antiviral T cell responses due to inflammatory environment, expression of inhibitory molecules, and effector caspase activity in T cells.

IMMUNITY (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Multidisciplinary Sciences

Vaccine efficacy probable against COVID-19 variants

Larry L. Luchsinger et al.

SCIENCE (2021)

Add to Collection

Article Microbiology

Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

Kuan-Ying A. Huang et al.

Summary: This study reports the complete mapping of antibody responses in three COVID-19 patients, finding cross-reactivity of antibodies with other betacoronaviruses and expansion of memory B cells upon SARS-CoV-2 infection. The anti-SARS-CoV-2 spike antibody clones target a diverse spectrum of epitopes, with potential of combination for combatting the outbreak.

PLOS PATHOGENS (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination

Venkata Viswanadh Edara et al.

Summary: This study investigates the neutralizing antibody response to 4 SARS-CoV-2 variants in individuals who have been infected or vaccinated.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

News Item Multidisciplinary Sciences

PFIZER COVID VACCINE PROTECTS AGAINST WORRYING VARIANTS

Ewen Callaway

NATURE (2021)

Add to Collection

Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes

William N. Voss et al.

Summary: The study found that in convalescent individuals from COVID-19, the IgG antibodies primarily target epitopes outside the receptor binding domain (RBD) in the spike glycoprotein. It also revealed a protective NTD antibody and an NTD epitope that is recurrently mutated in emerging SARS-CoV-2 variants.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

Chunyan Wang et al.

Summary: Research has isolated two human monoclonal antibodies from immunized humanized mice that display cross-reactivity against various beta coronaviruses, targeting the stem helix in the spike S2 fusion subunit. These antibodies block MERS-CoV infection in cells and provide protection against lethal MERS-CoV challenge in mice, showcasing their potential for developing broad-spectrum antibodies. Despite exhibiting cross-reactivity, the antibodies only neutralize MERS-CoV due to subtle epitope differences in the spike S2 fusion subunit.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Fatima Amanat et al.

Summary: After receiving the SARS-CoV-2 spike mRNA vaccine, individuals showed robust polyclonal antibody responses, with a majority of vaccine-induced antibodies lacking neutralizing activity. However, vaccine-induced RBD binding antibodies may offer substantial protection against viral variants carrying single E484K RBD mutations.

CELL (2021)

Add to Collection

Article Medical Laboratory Technology

Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer

Thomas Mueller

Summary: The study compared two serological assays from Roche Diagnostics in individuals with and without COVID-19 vaccination, revealing differences in antibody patterns between the two groups. In patients without vaccination, a high proportion had negative or positive results with the Roche assays, while healthcare-workers who received COVID-19 vaccination showed increasing levels of anti-spike antibodies post vaccination.

CLINICA CHIMICA ACTA (2021)

Add to Collection

Article Multidisciplinary Sciences

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

Jianying Liu et al.

Summary: Serum samples from individuals vaccinated with the BNT162b2 vaccine can neutralize various SARS-CoV-2 variants, indicating mass immunization as a central strategy to end the global COVID-19 pandemic.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

Pinja Jalkanen et al.

Summary: The study shows that the second dose of the BNT162b2 vaccine can induce cross-neutralization to some extent of SARS-CoV-2 variants, providing partial protection. Despite the reduced neutralization effect on the B.1.351 variant, the majority of vaccinees still have some level of protection.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Pathology

Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening

Megan Zilla et al.

Summary: This study evaluated the specificity and sensitivity of 6 SARS-CoV-2 antibody assays, showing most methods performed well in terms of specificity and sensitivity. Sensitivity of tests more than 21 days after symptom onset varied among different methods, with similar average days of seroconversion.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

A human monoclonal antibody blocking SARS-CoV-2 infection

Chunyan Wang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medical Laboratory Technology

Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients

Sarah E. Wheeler et al.

CLINICAL BIOCHEMISTRY (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Ching-Lin Hsieh et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Christopher O. Barnes et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Immunology

On the use of nonparametric tests for comparing immunological Reverse Cumulative distribution curves (RCDCs)

Robert D. Small et al.

VACCINE (2019)

Add to Collection

© Peeref 2019-2024. All rights reserved.